Statement Of Cash Flows [Abstract]

Alligator Bioscience - Filing #703045

Concept 2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Cash flows from (used in) operations before changes in working capital
130 587 SEK
132 863 SEK
Adjustments for decrease (increase) in trade and other receivables
13 589 SEK
2 119 SEK
Adjustments for increase (decrease) in trade and other payables
17 144 SEK
10 608 SEK
Income taxes paid, classified as operating activities
- SEK
- SEK
Cash flows from (used in) investing activities [abstract]
Cash flows from (used in) decrease (increase) in short-term deposits and investments
- SEK
103 160 SEK
Cash flows from (used in) financing activities [abstract]
Payments for share issue costs
33 897 SEK
- SEK

Talk to a Data Expert

Have a question? We'll get back to you promptly.